| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT07021989 ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma |
date change Primary completion pushed: 2029-03-31 -> 2029-05-31 |
| 2026-06-05 | NCT07021989 ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma |
date change Completion pushed: 2033-10-31 -> 2033-12-31 |
| 2026-06-04 | NCT00352534 Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or… |
Trial completed |
| 2026-06-03 | NCT03786783 Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly… |
Trial completed |
| 2026-06-03 | NCT03786783 Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly… |
date change Completion moved earlier: 2026-09-19 -> 2026-03-31 |
| 2026-06-02 | NCT04628767 Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients… |
Enrollment reduced: 249 -> 131 participants |
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
Trial completed |
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
date change Completion moved earlier: 2026-10-03 -> 2026-03-31 |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
date change Primary completion pushed: 2026-05-12 -> 2027-04-12 |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
date change Completion pushed: 2026-05-12 -> 2027-04-12 |
| 2026-05-27 | NCT07321912 Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma |
Recruitment opened |
| 2026-05-23 | NCT01190930 Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk… |
Trial completed |
| 2026-05-21 | NCT06549595 A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular… |
Trial sites expanded: 159 -> 193 locations |
| 2026-05-20 | NCT07387926 Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory… |
Primary endpoint(s) modified |
| 2026-05-20 | NCT07387926 Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory… |
date change Primary completion pushed: 2033-01-10 -> 2033-07-18 |
| 2026-05-20 | NCT07387926 Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory… |
date change Completion pushed: 2035-12-12 -> 2036-06-18 |
| 2026-05-16 | NCT06091865 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… |
overall status: "Active Not Recruiting" → "Recruiting" |
| 2026-05-16 | NCT06091865 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… |
Trial sites expanded: 149 -> 155 locations |
| 2026-05-16 | NCT06717347 A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus… |
Trial sites expanded: 253 -> 256 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07643103 Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative… | Phase 2 | Not Yet Recruiting |
| 2026-06-09 | NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… | Phase 2 | Not Yet Recruiting |
| 2026-06-08 | NCT07634471 A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) | Phase 2/3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06289673 | Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute… | Acute Lymphoblastic Leukemia | Recruiting |
| Phase 3 | |||
| NCT06220032 | Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With… | DLBCL - Diffuse Large B Cell Lymphoma | Recruiting |
| NCT03126916 | Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With… | Ganglioneuroblastoma | Recruiting |
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT05304585 | Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low… | Embryonal Rhabdomyosarcoma | Recruiting |
| NCT05382338 | A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss | Childhood Medulloblastoma | Recruiting |
| NCT06401330 | A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology… | Stage I Mixed Cell Type Kidney Wilms Tumor | Recruiting |
| NCT06647953 | Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary… | Pleuropulmonary Blastoma | Recruiting |
| NCT04043494 | International Cooperative Treatment Protocol for Children and Adolescents With… | Lymphoblastic Lymphoma, Childhood | Recruiting |
| NCT06091865 | A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… | Diffuse Large B-cell Lymphoma (DLBCL) | Recruiting |
| NCT06091254 | A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works… | Follicular Lymphoma (FL) | Recruiting |
| NCT06549595 | A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular… | Untreated Follicular Lymphoma | Recruiting |
| NCT06911502 | A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab… | Follicular Lymphoma | Recruiting |
| NCT04166409 | A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With… | Low Grade Astrocytoma | Recruiting |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT06191744 | Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral… | Follicular Lymphoma (FL) | Recruiting |
| NCT06717347 | A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus… | Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT05675410 | A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… | Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 | Recruiting |
| NCT06172296 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of… | Ganglioneuroblastoma, Nodular | Recruiting |
| NCT07348575 | A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination… | Lymphoma, Large-Cell, Diffuse | Enrolling by Invitation |
| NCT00887146 | Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy… | Brain and Central Nervous System Tumors | Active, Not Recruiting |
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | Acute Lymphoblastic Leukemia, Pediatric | Active, Not Recruiting |
| NCT06097364 | A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated… | Follicular Lymphoma (FL) | Active, Not Recruiting |
| NCT06356129 | Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus… | Large B-cell Lymphoma | Active, Not Recruiting |
| NCT07466316 | A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose… | Rhabdomyosarcoma | Not Yet Recruiting |